Results 11 to 20 of about 50,453 (194)
Role of posaconazole in the treatment of oropharyngeal candidiasis
Infection and Drug Resistance, 2010 Posaconazole is the newest azole antifungal approved by the US Food and Drug Administration, and possesses a broad spectrum of activity against numerous yeasts and filamentous fungi. It is available as an oral suspension and is generally well tolerated by patients, but gastrointestinal absorption is sometimes inadequate and remains a clinical concern ...
Voichita Ianas +2 more
doaj +8 more sources
Species distribution and
BMC Microbiology, 2008 Background In Tanzania, little is known on the species distribution and antifungal susceptibility profiles of yeast isolates from HIV-infected patients with primary and recurrent oropharyngeal candidiasis. Methods A total of 296 clinical oral yeasts were
Rijs Antonius JMM +9 more
doaj +3 more sources
Gastroenterologìa, 2016 The article presents the results of studying the sixth scale of comorbidity The Cumulative Illness Rating Scale, which represents the upper digestive tract diseases in patients with oropharyngeal candidiasis compared with patients without fungi and ...
I.V. Kushnirenko
doaj +2 more sources
Patient Preference and Adherence, 2011 Curtis D Collins1, Sarah Cookinham2, Jeannina Smith21Department of Pharmacy Services, 2Department of Medicine, Division of Infectious Disease, University of Michigan Health System, Ann Arbor, MI, USAAbstract: Oropharyngeal candidiasis is a very common ...
Cookinham S, Collins CD, Smith J
doaj +1 more source
CASPOFUNGIN IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS
International Journal of Clinical Practice, 2003 SUMMARYA patient with AIDS developed oropharyngeal candidiasis. Candida albicans and C. glabrata were isolated from the patient and found to be resistant to fluconazole and itraconazole in vitro. Voriconazole therapy was initiated, but discontinued when the C. albicans strain isolated from the patient was found to be resistant to it. The patient failed
Garbino, Jorge +3 more
core +5 more sources
Powder diet exacerbates oropharyngeal candidiasis in a mouse model. [PDF]
Appl Environ MicrobiolOropharyngeal candidiasis (OPC) is a multifactorial disease and a significant health concern. We found that the physical form of the diet plays a critical role in the severity and progression of OPC. We developed a modified cortisone OPC murine model that facilitates studies investigating pathogenesis and recovery processes.
Vazquez-Munoz R +3 more
europepmc +3 more sources
Caspofungin—a new therapeutic option for oropharyngeal candidiasis [PDF]
Clinical Microbiology and Infection, 2004 Patients with AIDS are often severely immunocompromised. These patients commonly develop opportunistic infections such as oropharyngeal candidiasis whose treatment may prove to be difficult. Caspofungin belongs to a new class of antifungal agents that have a different mode of action to azoles and polyenes.
J. Garbino, Garbino, J.
openaire +4 more sources
Miconazole Nitrate Microparticles in Lidocaine Loaded Films as a Treatment for Oropharyngeal Candidiasis [PDF]
Materials, 2023 Maximiliano Sortino +2 more
exaly +2 more sources
Clotrimazole-Loaded Borneol-Based In Situ Forming Gel as Oral Sprays for Oropharyngeal Candidiasis Therapy [PDF]
Gels, 2023 Thawatchai Phaechamud +2 more
exaly +2 more sources
Oropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran
Current Medical Mycology, 2015 Background and Purpose: Over the past years, the role of fungi as a cause of nosocomial infections in hospitalized patients has been accentuated. Candida species constitute an important group of fungi causing diseases in immunocompromised patients ...
Fariba Berenji +5 more
doaj +1 more source